Nitrite formulations and their use as nitric oxide prodrugs
View Patent ↗Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of the composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.
1. A method of reducing a patient's triglyceride level, comprising:
administering to the patient a composition in a form of a lozenge dissolvable in the mouth, the composition comprising:
from about 40 weight parts to about 1000 weight parts of a botanical nitrate source;
from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity;
from about 20 weight parts to about 500 weight parts L-citrulline; and
from about 4 weight parts to about 100 weight parts of a nitrite salt.
2. The method of claim 1 , wherein the botanical nitrate source is selected from the group consisting of beet root, artichoke, holy basil, gingko, and mixtures thereof and is present at about 200 weight parts;
the botanical source of nitrite reduction activity is selected from the group consisting of hawthorn berry, Schisandra, green tea, beet root, pine bark, and mixtures thereof and is present at about 100 weight parts;
the L-citrulline is present at about 100 weight parts; and
the nitrite salt is selected from the group consisting of sodium nitrite, potassium nitrite, and mixtures thereof and is present at about 20 weight parts;
and the composition further comprises:
about 1 weight part vitamin B12 in a form selected from the group consisting of methylcobalamin, cyanocobalamin, and mixtures thereof;
about 100 weight parts vitamin C in a form selected from the group consisting of magnesium ascorbate, ascorbic acid, and mixtures thereof; and
from about 50 weight parts to about 1500 weight parts of one or more ingredients selected from the group consisting of mannitol, xylitol, sorbitol, sugar alcohols, cellulose, cellulose esters, cellulose ethers, starch, polysaccharides, oligosaccharides, disaccharides, saccharides, gelatin, polyvinylpyrrolidone, polyethylene glycol, binders, flavorants, colorants, magnesium stearate, antiadherent agents, stearate salts, sweeteners, silica, and lubricants.
3. The method of claim 2 , wherein the lozenge weighs from about 600 mg to about 2000 mg.
4. The method of claim 2 , wherein the administering is performed once or twice daily.